Rose hip inhibits chemotaxis and chemiluminescence of human peripheral blood neutrophils in vitro and reduces certain inflammatory parameters in vivo

被引：45

作者：

Kharazmi A. ^{[1
]}

Winther K. ^{[2
]}

机构：

[1] Department of Clinical Microbiology, Rigshospitalet Afsnit 7806, DK-2200 Copenhagen

[2] Department of Clinical Chemistry, Kolding Hospital, Kolding

来源：

InflammoPharmacology | 1999年 / 7卷 / 4期

关键词：

Antiinflammatory; Chemotaxis; CRP; Neutrophil; Rosa canina; Rose hip;

D O I：

10.1007/s10787-999-0031-y

中图分类号：

学科分类号：

摘要：

Objective and Design: The objective of this study was to investigate the leucocyte-related antiinflammatory properties of rose hip. Materials and Methods: The effect of rose hip on a number of inflammatory parameters was evaluated using the following models: (1) The effect of rose hip extract on chemotaxis and chemiluminescence of peripheral blood polylnorphonuclear leucocytes (PMNs) from healthy subjects in vitro; (2) The effect of rose hip administered to healthy subjects on serum levels of creatinine and C-reactive protein and on chemotaxis and chemiluminescence of peripheral blood PMNs. Results: Rose hip extract at concentrations higher than 500 μg/ml inhibited the chemotaxis and chemiluminescence of peripheral blood polymorphonuclear leucocytes in vitro. Daily intake of rose hip powder at doses of 45 grams or lower by healthy subjects resulted in reduced chemotaxis of peripheral blood PMNs and reduced the level of serum creatinine and acute phase protein CRP. Conclusions: These results indicate that rose hip possesses antiinflammatory properties and might be used as a replacement or supplement for conventional drug therapies in some inflammatory diseases such as arthritis.

引用

页码：377 / 386

页数：9

共 11 条

[1]

Hochberger M.C., Airman R.D., Brandt K.D., Clarck B.M., Dieppe P.A., Griffin M.R., Moskowitz R.W., Schnitzer T.J., Guidelines for the medical management of osteoarthritis (Part I), Arthritis Rheum., 38, pp. 1535-1540, (1995)

[2]

Hochberger M.C., Altman R.D., Brandt K.D., Clarck B.M., Dieppe P.A., Griffin M.R., Moskowitz R.W., Schnitzer T.J., Guidelines for the medical management of oseteoarthritis (Part 2), Arthritis Rheum., 38, pp. 1541-1546, (1995)

[3]

Jensen P., Kharazmi A., Computer-assisted image analysis assay of human neutrophil chemotaxis in vitro, J. Immunol. Methods, 144, pp. 43-48, (1991)

[4]

Kaplan H.B., Edelson H.S., Korchak H.M., Given W.P., Abramson S., Weismann G., Effect of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo, Biochem. Pharmacol., 33, pp. 371-378, (1984)

[5]

Kemp A., Smith J., The effect of salicylate on human leukocyte migration, Clin. Exp. Immunol., 49, pp. 233-238, (1982)

[6]

Kharazmi A., Hoiby N., Doring G., Valerius N.H., Pseudomonas aeruginosa exopro- teases inhibit human neutrophil chemiluminescence, Infect. Immun., 44, pp. 587-591, (1986)

[7]

Maderazo E.G., Breaux S.P., Woronick C.L., Inhibition of human polymorphonuclear leukocyte cell response by ibuprofen, J. Pharm. Sci., 73, pp. 1403-1406, (1986)

[8]

Matzner Y., Drexler R., Levy M., Effect of dipyrone, acetylsalicylic acid and acetaminophen on human neutrophil chemotaxis, Eur. J. Clin. Invest., 14, pp. 440-443, (1984)

[9]

Ridker P.M., Cushman M., Stampfer M.J., Tracey R.P., Hennekens C.H., Inflammation, aspirin and the risk of cardiovascular diseases in apparently healthy men, N. Eng. J. Med., 336, pp. 973-979, (1997)

[10]

Rivkin I., Foschi V., Rosen C.H., Inhibition of in vitro neutrophil chemotaxis and spontaneous motility by anti-inflammatory agents (39518), Proc. Soc. Exp. Biol. Med., 153, pp. 236-240, (1976)

← 1 2 →